Literature DB >> 19732470

Dietary flavonoid intake and colorectal cancer: a case-control study.

Janet A M Kyle1, Linda Sharp, Julian Little, Garry G Duthie, Geraldine McNeill.   

Abstract

Diets rich in flavonoids may reduce the risk of developing colorectal cancer. Flavonoids are widely distributed in foods of plant origin, though in the UK tea is the main dietary source. Our objective was to evaluate any independent associations of total dietary and non-tea intake of four flavonoid subclasses and the risk of developing colorectal cancer in a tea-drinking population with a high colorectal cancer incidence. A population-based case-control study (264 cases with histologically confirmed incident colorectal cancer and 408 controls) was carried out. Dietary data gathered by FFQ were used to calculate flavonoid intake. Adjusted OR and 95 % CI were estimated by logistic regression. No linear association between risk of developing colorectal cancer and total dietary flavonol, procyanidin, flavon-3-ol or flavanone intakes was found, but non-tea flavonol intake was inversely associated with colorectal cancer risk (OR 0.6; 95 % CI 0.4, 1.0). Stratification by site of cancer and assessment of individual flavonols showed a reduced risk of developing colon but not rectal cancer with increasing non-tea quercetin intake (OR 0.5; 95 % CI 0.3, 0.8; P(trend) < 0.01). We concluded that flavonols, specifically quercetin, obtained from non-tea components of the diet may be linked with reduced risk of developing colon cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19732470     DOI: 10.1017/S0007114509991784

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  25 in total

1.  Apigenin induces apoptosis by targeting inhibitor of apoptosis proteins and Ku70-Bax interaction in prostate cancer.

Authors:  Sanjeev Shukla; Pingfu Fu; Sanjay Gupta
Journal:  Apoptosis       Date:  2014-05       Impact factor: 4.677

2.  Association of dietary quercetin with reduced risk of proximal colon cancer.

Authors:  Zora Djuric; Richard K Severson; Ikuko Kato
Journal:  Nutr Cancer       Date:  2012-03-19       Impact factor: 2.900

3.  Dietary lignan and proanthocyanidin consumption and colorectal adenoma recurrence in the Polyp Prevention Trial.

Authors:  Gerd Bobe; Gwen Murphy; Paul S Albert; Leah B Sansbury; Elaine Lanza; Arthur Schatzkin; Amanda J Cross
Journal:  Int J Cancer       Date:  2011-08-01       Impact factor: 7.396

Review 4.  Colon Cancer: What We Eat.

Authors:  Pan Pan; Jianhua Yu; Li-Shu Wang
Journal:  Surg Oncol Clin N Am       Date:  2017-12-15       Impact factor: 3.495

Review 5.  [Colorectal cancer prevention by flavonoids].

Authors:  Harald Hoensch; Elke Richling; Wolfgang Kruis; Wilhelm Kirch
Journal:  Med Klin (Munich)       Date:  2010-09-08

Review 6.  Xenoestrogens challenge 17β-estradiol protective effects in colon cancer.

Authors:  Maria Marino
Journal:  World J Gastrointest Oncol       Date:  2014-03-15

7.  Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.

Authors:  Sanjeev Shukla; Natarajan Bhaskaran; Melissa A Babcook; Pingfu Fu; Gregory T Maclennan; Sanjay Gupta
Journal:  Carcinogenesis       Date:  2013-09-25       Impact factor: 4.944

Review 8.  Dietary flavonoid intake and risk of stomach and colorectal cancer.

Authors:  Hae Dong Woo; Jeongseon Kim
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

9.  The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk.

Authors:  Andrea Y Angstadt; Arthur Berg; Junjia Zhu; Paige Miller; Terryl J Hartman; Samuel M Lesko; Joshua E Muscat; Philip Lazarus; Carla J Gallagher
Journal:  Cancer       Date:  2013-04-10       Impact factor: 6.860

10.  Microencapsulated Bifidobacterium bifidum and Lactobacillus gasseri in Combination with Quercetin Inhibit Colorectal Cancer Development in ApcMin/+ Mice.

Authors:  Iván Benito; Ignacio J Encío; Fermín I Milagro; María Alfaro; Ana Martínez-Peñuela; Miguel Barajas; Florencio Marzo
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.